4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-22-023916
Chief Operating Officer sold 831 shares at $13.17 ($10,944)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ADAMS R MARK Chief Operating Officer | 2022-04-07 | Sale | −831 | $13.17 | $10,944 | 122,893 | D |
| Open-market sales · 831 sh · avg $13.17 · $10,944 | |||||||
Loading xslF345X03/doc4.xml…